There Might Actually( Finally !) Be A Cure For Herpes

Herpes can be scary as hell.

Even though its nowherenear as dangerous as other STDs likegonorrhea, chlamydiaand HPV, the stigma around herpes is so bad, were scared of the social ramifications if we contract it.

Its also super common: According to WHO, 67 percent of people worldwide under the age of 50 have HSV-1( the virus that causes oral herpes ), and 11 percent of people aged 15 to 49 have HSV-2( the virus that causes genital herpes ).

There has never been a remedy for herpes until maybe, potentially , now.

A new, 3-shot herpes therapy( a therapeutic inoculation) calledTheravax HSV-2 is still in itssuper early trial stages, but itsbeen shown to reduce symptoms more effectively than antiviral narcotics already on the market. Which is HUGE.

In short, Theravax HSV-2 has already significantlyimproved the lives of people who have HSV-1 and HSV-2.

Dr.William Halford, chief science officer of Rational Vaccines, has been researching this vaccine in pre-clinical examines for overa decade. He believes the antiviral narcotics physicians have been using for the past 30 years have simply not been very successful in stopping thespread of herpes.

Over one million people per week continues its work newly infected with HSV-1 or HSV-2, Halford tells. Its time to offer herpes sufferers a 21 st century answer with the potential to not only better treat herpes, but to simply stop the spread of the disease.

While herpes is certainly not the most threateningdisease in the world, people with herpes suffer huge social outcomes. Herpes gags in nearly every Judd Apatowmoviesuggest peoplewith herpes are whores, or that literally anything wouldbe better than getting herpes.

Hopefully this therapeutic inoculation will help people with the STDfeel less stigmatized.

How Your Emotions Can Impact Your Physical Health

Are in favour of Elite Daily’s official newsletter, The Edge, for more stories you don’t want to miss .

Read more:

Leave a Reply

Your email address will not be published. Required fields are marked *